IL131594A - Method and diagnostic kit for early detection of gastrointestinal cancer - Google Patents
Method and diagnostic kit for early detection of gastrointestinal cancerInfo
- Publication number
- IL131594A IL131594A IL13159498A IL13159498A IL131594A IL 131594 A IL131594 A IL 131594A IL 13159498 A IL13159498 A IL 13159498A IL 13159498 A IL13159498 A IL 13159498A IL 131594 A IL131594 A IL 131594A
- Authority
- IL
- Israel
- Prior art keywords
- cox
- mrna
- diagnostic kit
- cancer
- gastric
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6841—In situ hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI971124A FI971124A0 (fi) | 1997-03-18 | 1997-03-18 | Metod foer diagnostisering av magcancer |
| PCT/FI1998/000238 WO1998041864A1 (en) | 1997-03-18 | 1998-03-18 | Diagnosis of early gastric cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL131594A0 IL131594A0 (en) | 2001-01-28 |
| IL131594A true IL131594A (en) | 2004-02-19 |
Family
ID=8548414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13159498A IL131594A (en) | 1997-03-18 | 1998-03-18 | Method and diagnostic kit for early detection of gastrointestinal cancer |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6416961B1 (fi) |
| EP (1) | EP0968421B1 (fi) |
| JP (1) | JP2001519900A (fi) |
| KR (1) | KR20000076291A (fi) |
| CN (1) | CN1250523A (fi) |
| AT (1) | ATE272838T1 (fi) |
| AU (1) | AU732228B2 (fi) |
| BR (1) | BR9808378A (fi) |
| CA (1) | CA2284048A1 (fi) |
| DE (1) | DE69825431T2 (fi) |
| DK (1) | DK0968421T3 (fi) |
| ES (1) | ES2226105T3 (fi) |
| FI (1) | FI971124A0 (fi) |
| IL (1) | IL131594A (fi) |
| NO (1) | NO994440L (fi) |
| NZ (1) | NZ338068A (fi) |
| PT (1) | PT968421E (fi) |
| RU (1) | RU2204835C2 (fi) |
| TR (1) | TR199902298T2 (fi) |
| WO (1) | WO1998041864A1 (fi) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6335193B1 (en) * | 1999-04-15 | 2002-01-01 | Padmanabhan P Nair | Isolated colonocytes |
| AU2543301A (en) * | 2000-01-14 | 2001-07-24 | Vera Genics Ltd. | Method and kit for diagnosis of neoplastic transformation |
| JP5122713B2 (ja) | 2000-03-27 | 2013-01-16 | トーマス ジェファーソン ユニバーシティ | 癌細胞を同定およびターゲティングするための組成物および方法 |
| AU2001251223A1 (en) * | 2000-03-30 | 2001-10-15 | Diadexus, Inc. | Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer |
| CA2451483C (en) * | 2001-06-25 | 2011-02-15 | Oncomedx, Inc. | Methods for detecting and monitoring cox-2 rna in plasma and serum |
| WO2003060121A2 (en) * | 2001-12-21 | 2003-07-24 | Diadexus, Inc. | Compositions and methods relating to gastric specific genes and proteins |
| KR100475642B1 (ko) * | 2001-12-29 | 2005-03-10 | 한국생명공학연구원 | 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트 |
| EP1523577A2 (en) * | 2002-07-10 | 2005-04-20 | Oncotherapy Science, Inc. | Method for diagnosis of intestinal-type gastric tumors |
| EP1554408A2 (en) * | 2002-10-25 | 2005-07-20 | Oncotherapy Science, Inc. | Method for diagnosing diffuse-type gastric cancers |
| JP4936887B2 (ja) * | 2003-07-17 | 2012-05-23 | パシフィック エッジ バイオテクノロジー リミティド | 胃ガンの検出用マーカー |
| US20050014165A1 (en) * | 2003-07-18 | 2005-01-20 | California Pacific Medical Center | Biomarker panel for colorectal cancer |
| US20050075543A1 (en) * | 2003-10-03 | 2005-04-07 | Calabrese Charles A. | Method of anonymous medical testing and providing the patient with the test results |
| KR100645979B1 (ko) * | 2004-08-09 | 2006-11-15 | 한국생명공학연구원 | 위암 유전자 마커 및 이를 이용한 위암 진단킷트 |
| US20080032943A1 (en) * | 2005-11-04 | 2008-02-07 | Johji Inazawa | Method for detecting cancer and a method for suppressing cancer |
| RU2613139C1 (ru) * | 2015-10-12 | 2017-03-15 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ дифференциальной диагностики рака желудка различных гистологических типов |
| RU2613300C1 (ru) * | 2015-11-10 | 2017-03-15 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Способ диагностики низко дифференцированного нейроэндокринного рака желудка |
| RU2642989C1 (ru) * | 2016-12-19 | 2018-01-29 | федеральное государственное автономное образовательное учреждение высшего образования "Санкт-Петербургский политехнический университет Петра Великого" (ФГАОУ ВО "СПбПУ") | Способ диагностики онкологических заболеваний |
| CN109387635A (zh) * | 2018-11-07 | 2019-02-26 | 国家纳米科学中心 | 基于热泳细胞外囊泡检测的胃癌检测系统及方法 |
| RU2743221C1 (ru) * | 2020-10-12 | 2021-02-16 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации | Способ определения типа рака желудка по классификации lauren методом компьютерной томографии |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459239A (en) | 1994-01-24 | 1995-10-17 | Merck Frosst Canada Inc. | Peptide sequences and antipeptide antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2 proteins |
-
1997
- 1997-03-18 FI FI971124A patent/FI971124A0/fi not_active Application Discontinuation
-
1998
- 1998-03-18 TR TR1999/02298T patent/TR199902298T2/xx unknown
- 1998-03-18 PT PT98909537T patent/PT968421E/pt unknown
- 1998-03-18 EP EP98909537A patent/EP0968421B1/en not_active Expired - Lifetime
- 1998-03-18 US US09/381,042 patent/US6416961B1/en not_active Expired - Lifetime
- 1998-03-18 DE DE69825431T patent/DE69825431T2/de not_active Expired - Lifetime
- 1998-03-18 ES ES98909537T patent/ES2226105T3/es not_active Expired - Lifetime
- 1998-03-18 DK DK98909537T patent/DK0968421T3/da active
- 1998-03-18 JP JP54017498A patent/JP2001519900A/ja active Pending
- 1998-03-18 RU RU99121656/14A patent/RU2204835C2/ru not_active IP Right Cessation
- 1998-03-18 AU AU64041/98A patent/AU732228B2/en not_active Ceased
- 1998-03-18 IL IL13159498A patent/IL131594A/en active IP Right Grant
- 1998-03-18 KR KR1019997008388A patent/KR20000076291A/ko not_active Application Discontinuation
- 1998-03-18 CA CA002284048A patent/CA2284048A1/en not_active Abandoned
- 1998-03-18 NZ NZ338068A patent/NZ338068A/xx unknown
- 1998-03-18 CN CN98803363A patent/CN1250523A/zh active Pending
- 1998-03-18 AT AT98909537T patent/ATE272838T1/de not_active IP Right Cessation
- 1998-03-18 WO PCT/FI1998/000238 patent/WO1998041864A1/en not_active Application Discontinuation
- 1998-03-18 BR BR9808378-3A patent/BR9808378A/pt not_active Application Discontinuation
-
1999
- 1999-09-13 NO NO994440A patent/NO994440L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2204835C2 (ru) | 2003-05-20 |
| BR9808378A (pt) | 2000-05-23 |
| DE69825431D1 (de) | 2004-09-09 |
| ATE272838T1 (de) | 2004-08-15 |
| TR199902298T2 (xx) | 2000-01-21 |
| FI971124A0 (fi) | 1997-03-18 |
| CA2284048A1 (en) | 1998-09-24 |
| IL131594A0 (en) | 2001-01-28 |
| KR20000076291A (ko) | 2000-12-26 |
| NO994440L (no) | 1999-11-18 |
| US6416961B1 (en) | 2002-07-09 |
| AU6404198A (en) | 1998-10-12 |
| WO1998041864A1 (en) | 1998-09-24 |
| EP0968421B1 (en) | 2004-08-04 |
| DE69825431T2 (de) | 2005-07-28 |
| PT968421E (pt) | 2004-10-29 |
| AU732228B2 (en) | 2001-04-12 |
| NO994440D0 (no) | 1999-09-13 |
| DK0968421T3 (da) | 2004-12-06 |
| ES2226105T3 (es) | 2005-03-16 |
| EP0968421A1 (en) | 2000-01-05 |
| JP2001519900A (ja) | 2001-10-23 |
| CN1250523A (zh) | 2000-04-12 |
| NZ338068A (en) | 2001-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0968421B1 (en) | Diagnosis of early gastric cancer | |
| Ristimäki et al. | Expression of cyclooxygenase-2 in human gastric carcinoma | |
| Van Rees et al. | Cyclooxygenase‐2 expression during carcinogenesis in the human stomach | |
| Okami et al. | Overexpression of cyclooxygenase-2 in carcinoma of the pancreas | |
| Nakashima et al. | Cyclin D1 overexpression in thyroid tumours from a radio‐contaminated area and its correlation with Pin1 and aberrant β‐catenin expression | |
| Rask et al. | Ovarian epithelial cancer: a role for PGE 2-synthesis and signalling in malignant transformation and progression | |
| Dreher et al. | Reduction of PTEN and p27 Kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies | |
| Gustafsson et al. | EP1–4 subtype, COX and PPARγ receptor expression in colorectal cancer in prediction of disease‐specific mortality | |
| AU2010291710B2 (en) | Methods and compositions for detection of lethal cell and uses thereof | |
| Qiu et al. | Significance of cyclooxygenase-2 expression in human primary hepatocellular carcinoma | |
| Ho et al. | Prostate cancer cell phenotypes based on AGR2 and CD10 expression | |
| Shappell | Clinical utility of prostate carcinoma molecular diagnostic tests | |
| Kim et al. | Aberrant maspin expression is involved in early carcinogenesis of gallbladder cancer | |
| Yu et al. | Inactivation of myopodin expression associated with prostate cancer relapse | |
| Ito et al. | Frequent expression of Niban in head and neck squamous cell carcinoma and squamous dysplasia | |
| Guijarro et al. | MAP17 overexpression is a common characteristic of carcinomas | |
| Esteban et al. | Diagnostic and prognostic utility of methylation and protein expression patterns of myopodin in colon cancer | |
| Schreiber et al. | Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging | |
| Tatsuwaki et al. | Reduction of 15‐hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma | |
| Song et al. | Genetic alterations and expression pattern of CEACAM1 in colorectal adenomas and cancers | |
| Murai et al. | Aberrant maspin expression in human endometrial cancer | |
| Pulte et al. | Sentinel lymph node mapping and molecular staging in nonsmall cell lung carcinoma | |
| Jiang et al. | Expression of cyclooxygenase-2 in human esophageal squamous cell carcinomas | |
| Nam et al. | Expression of HMGI (Y) associated with malignant phenotype of human gastric tissue | |
| Venerito et al. | Effects of low‐dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin‐E2 do not depend on Helicobacter pylori infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |